Tinubu signs executive order to slash pharmaceutical prices
- President Bola Tinubu signed an executive order to boost local pharmaceutical production in Nigeria, aiming to reduce healthcare costs through increased local manufacturing.
- The order introduces zero tariffs, excise duties, and VAT on imported machinery, equipment, and raw materials for pharmaceutical production, enhancing the competitiveness of local manufacturers.
- The initiative involves collaboration among various government ministers and agencies to expedite implementation, reduce regulatory bottlenecks, and establish market-shaping mechanisms to support local manufacturers, generating economic growth and job creation in the healthcare sector.
Join Our Newsletter
Get the latest news, updates, and exclusive content delivered straight to your inbox.
Boosting Local Production and Reducing Healthcare Costs
President Bola Tinubu Signs Historic Executive Order to Enhance Local Pharmaceutical Production
President Bola Tinubu has taken a significant step towards revitalizing Nigeria's health sector by signing an executive order aimed at increasing local production of healthcare products. This bold move is expected to reduce the escalating costs of medications nationwide, which have been exacerbated by the exit of some multinational pharmaceutical companies from the country.
Zero Tariffs and Excise Duties on Imported Pharmaceutical Inputs
The order introduces zero tariffs, excise duties, and Value-Added Tax (VAT) on specified machinery, equipment, and raw materials imported for pharmaceutical production. This measure is crucial in reducing production costs and enhancing the competitiveness of local manufacturers.
Boosting Local Manufacturing and Job Creation
The new order is pivotal to the success of the initiative for unlocking the healthcare value chain, which was approved in October 2023 by the President. It mandates collaboration between the Ministers of Health, Finance, and Industry, Trade and Investment to develop a harmonized implementation framework, expediting regulatory approvals and reducing bottlenecks.
Specific Items Covered by the Order
The specified items covered by the order include Active Pharmaceutical Ingredients (APIs), excipients, other essential raw materials required for manufacturing crucial health products like drugs, syringes, and needles, Long-lasting Insecticidal Nets (LLINs), and Rapid Diagnostic Kits, among others.
Market-Shaping Mechanisms to Encourage Local Manufacturers
The order also provides for establishing market-shaping mechanisms such as framework contracts and volume guarantees to encourage local manufacturers. This is expected to create a more favorable environment for local businesses to thrive and contribute to the nation's economic growth.
Agencies Involved in Swift Implementation
The swift implementation of this order is ensured by agencies including the Nigeria Customs Service, National Agency for Food and Drug Administration and Control (NAFDAC), Standard Organisation of Nigeria (SON), and Federal Inland Revenue Service (FIRS). These agencies will provide special waivers and exemptions effective for two years to support the initiative.
Impact on the Healthcare Sector
The implication of this order is a pivot towards market-based incentives to encourage medical industrialization, reducing costs of medical products through import substitution over time, creating and retaining economic value, and enabling job creation in the healthcare value chain.
Support for Local Drug Manufacturing Facilities
As of February, the National Agency for Food and Drug Administration and Control (NAFDAC) reported that a total of 105 applications for the construction and erection of drug manufacturing facilities have been approved across the country. Additionally, over 20 newly registered local drug manufacturers have cumulatively invested over $2 billion in the erection and completion of WHO-compliant facilities that manufacture quality pharmaceuticals and essential medicines for Nigerians.
President's Commitment to Healthcare Development
President Bola Tinubu has shown his commitment to ensuring Nigeria is put back on the path to prosperity by signing this transformative executive order. The order provides business opportunities for youth corps members and is expected to herald a new era of economic growth and job creation in the healthcare sector.
Future Prospects
The future prospects of this order are promising, as it aims to reduce Nigeria's over-dependence on importation and enhance the country's self-sufficiency in pharmaceutical production. This move is expected to benefit not only the healthcare sector but also the broader economy by creating new job opportunities and increasing economic value.
Conclusion
In conclusion, President Bola Tinubu's signing of the executive order to slash pharmaceutical prices is a significant step towards revitalizing Nigeria's health sector. The order introduces zero tariffs, excise duties, and VAT on specified machinery, equipment, and raw materials, aiming to reduce production costs and enhance local manufacturers' competitiveness. This move is expected to create a more favorable environment for local businesses to thrive, reduce the costs of medical products, and enable job creation in the healthcare value chain, ultimately benefiting the nation's economic growth and prosperity.
Read Also: Tinubu sympathizes with Abuja market fire victims
Read Also: Tinubu signs executive order to boost local production of healthcare products
Read Also: Tinubu signs executive order to slash pharmaceutical prices
